Literature DB >> 24080807

New developments in the diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome.

Michel Pontari1, Laura Giusto.   

Abstract

PURPOSE OF REVIEW: To describe new developments in the diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome (CPPS). RECENT
FINDINGS: Symptoms in men with chronic prostatitis/CPPS appear to cluster into a group with primarily pelvic or localized disease, and a group with more systemic symptoms. Several other chronic pain conditions can be associated with chronic prostatitis/CPPS, including irritable bowel syndrome, fibromyalgia, and chronic fatigue syndrome. Markers of neurologic inflammation and autoimmune disease parallel changes in symptoms after treatment. Treatment options include new alpha-blockers, psychological intervention, and prostate-directed therapy. The areas of acupuncture and pelvic floor physical therapy/myofascial release have received increased recent attention and appear to be good options in these patients. Future therapy may include antibodies to mediators of neurogenic inflammation and even treatment of bacteria in the bowel.
SUMMARY: The diagnosis of chronic prostatitis/CPPS must include conditions traditionally outside the scope of urologic practice but important for the care of men with chronic pelvic pain. The treatment is best done using multiple simultaneous therapies aimed at the different aspects of the condition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24080807     DOI: 10.1097/MOU.0b013e3283656a55

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  11 in total

Review 1.  Immune mediators of chronic pelvic pain syndrome.

Authors:  Stephen F Murphy; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Nat Rev Urol       Date:  2014-04-01       Impact factor: 14.432

2.  [Chronic pelvic pain syndrome : Treatment options using osteopathy].

Authors:  S Marx
Journal:  Urologe A       Date:  2017-08       Impact factor: 0.639

Review 3.  Anorectal and Pelvic Pain.

Authors:  Adil E Bharucha; Tae Hee Lee
Journal:  Mayo Clin Proc       Date:  2016-10       Impact factor: 7.616

Review 4.  The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis.

Authors:  Xiangbin Kong; Weiwei Hu; Zhilong Dong; Junqiang Tian; Yuhan Wang; Chen Jin; Chaozhao Liang; Zongyao Hao; Zhiping Wang
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-07-07       Impact factor: 5.554

5.  Pain and Urinary Symptoms Should Not be Combined into a Single Score: Psychometric Findings from the MAPP Research Network.

Authors:  James W Griffith; Alisa J Stephens-Shields; Xiaoling Hou; Bruce D Naliboff; Michel Pontari; Todd C Edwards; David A Williams; J Quentin Clemens; Niloofar Afari; Frank Tu; R Brett Lloyd; Donald L Patrick; Chris Mullins; John W Kusek; Siobhan Sutcliffe; Barry A Hong; H Henry Lai; John N Krieger; Catherine S Bradley; Jayoung Kim; J Richard Landis
Journal:  J Urol       Date:  2015-11-14       Impact factor: 7.450

6.  IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP).

Authors:  Stephen F Murphy; Anthony J Schaeffer; Joseph Done; Larry Wong; Ashlee Bell-Cohn; Kenny Roman; John Cashy; Michelle Ohlhausen; Praveen Thumbikat
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

7.  The efficacy of mirodenafil for chronic prostatitis/chronic pelvic pain syndrome in middle-aged males.

Authors:  Do Hoon Kong; Chang Jin Yun; Hyun Jun Park; Nam Cheol Park
Journal:  World J Mens Health       Date:  2014-12-29       Impact factor: 5.400

8.  Nociceptive and inflammatory mediator upregulation in a mouse model of chronic prostatitis.

Authors:  Erica S Schwartz; Amy Xie; Jun-Ho La; G F Gebhart
Journal:  Pain       Date:  2015-08       Impact factor: 7.926

9.  Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer.

Authors:  Onita Bhattasali; Leonard N Chen; Jennifer Woo; Jee-Won Park; Joy S Kim; Rudy Moures; Thomas Yung; Siyuan Lei; Brian T Collins; Keith Kowalczyk; Simeng Suy; Anatoly Dritschilo; John H Lynch; Sean P Collins
Journal:  Radiat Oncol       Date:  2014-02-11       Impact factor: 3.481

10.  Electroacupuncture improves trinitrobenzene sulfonic Acid-induced colitis, evaluated by transcriptomic study.

Authors:  Tin-Yun Ho; Hsin-Yi Lo; De-Cheng Chao; Chia-Cheng Li; Jau-Jin Liu; Chingju Lin; Chien-Yun Hsiang
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.